Mylan
Myhep all
"MYHEP ALL" contains Drug / Molecule called “Velpatasvir & Sofosbuvir”. MYHEP ALL has high overall cure rates of 99% for GT2 patients† and 95% for GT3 patients‡. Velpanat was also found to be highly effective in patients with GT1, GT4, GT5 and GT6, with overall cure rates ranging from 97–100%.
Indication
MYHEP ALL is helpful for treatment of all Hepatitis C adults that are suffering from genotype 1-6 chronic hepatitis C virus.
Note
Precaution
- Myhep All is a prescription drug and should be used under proper medical guidance and advice.
- Caution should be exercised in patients with history of stomach problem, liver, kidney, or heart disease during pregnancy and breastfeeding.
Updated On Oct 17, 2019 by Admin
Strength
100 mg Velpatasvir / 400 mg Sofosbuvir
Packing
1*28 Tablets (Bottle)
Storage
Store at room temperature (25 C).
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Velpanat
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
Hetero Healthcare Ltd. (INDIA)
Ledifos
Mylan
Mydacla
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)